A Randomized, Placebo-Controlled, Phase II Trial of Intravenous Allogeneic Non-HLA Matched, Unrelated Donor, Cord Blood Infusion for Ischemic Stroke. uri icon

authors

  • Daniel Laskowitz, MD, MHS
  • Jones, William
  • Volpi, John J
  • Marrotte, Eric
  • Kurtzberg, Joanne
  • Troy, Jesse
  • Poehlein, Emily
  • Bennett, Ellen R
  • Shpall, Elizabeth J
  • Wingard, John R
  • Freed, Brian
  • Belagaje, Samir R
  • Khanna, Anna

publication date

  • December 10, 2023